Management of dystonia of the lateral pterygoid muscle with botulinum toxin A.

Abstract

Oromandibular dystonia (OMD) is a rare neurological condition infrequently seen by oral and maxillofacial surgeons which may result in inappropriate deviation of the mandible, subluxation and intraoral soft tissue trauma. A case is presented of a patient suffering from spasmodic torticollis and lateral pterygoid dystonia and currently under treatment with botulinum A toxin (Botox) injections. Botox has emerged as the most effective form of symptomatic treatment for abnormabilities in muscle movement, namely dystonia with oromandibular symptoms.

• Authors: R Amaral Mendes, L G Upton
• Journal: The British journal of oral & maxillofacial surgery (Br J Oral Maxillofac Surg) Vol. 47 Issue 6 Pg. 481-3 (Sep 2009) ISSN: 1532-1940 [Electronic] Scotland
• PMID: 18829144 (Publication Type: Case Reports, Journal Article)

Chemical References

• Botulinum Toxins, Type A

Topics

• Botulinum Toxins, Type A (administration & dosage)
• Dystonia (drug therapy)
• Female
• Humans
• Injections, Intramuscular
• Middle Aged
• Pterygoid Muscles (drug effects, physiopathology)
• Torticollis (drug therapy)